The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $62.25

Today's change0.00 0.00%
Updated January 18 4:02 PM EST. Delayed by at least 15 minutes.
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $62.25

Today's change0.00 0.00%
Updated January 18 4:02 PM EST. Delayed by at least 15 minutes.

USANA Health Sciences Inc unchanged

USANA Health Sciences Inc is unchanged Wednesday sitting at (U.S.)$62.25. Over the last five days, shares have gained 1.30% and 4.81% over the last 52 weeks. However, this lagged the 20.76%. gain in the S&P 500.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $62.25
  • High--
  • Low--
  • Bid / Ask(U.S.) $59.00 / (U.S.) $65.00
  • YTD % change+1.72%
  • Volume0
  • Average volume (10-day)85,916
  • Average volume (1-month)104,508
  • Average volume (3-month)127,563
  • 52-week range(U.S.) $46.00 to (U.S.) $75.00
  • Beta1.07
  • Trailing P/E15.42×
  • P/E 1 year forward15.32×
  • Forward PEG1.53×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $4.04
Updated January 18 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.36%

Based on its net profit margin of 10.36%, USANA Health Sciences Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 01, 201610/01/2016Jul 02, 201607/02/2016Apr 02, 201604/02/2016Jan 02, 201601/02/2016
Revenue254259240233
Total other revenue--------
Total revenue254259240233
Gross profit209213198192
Total cost of revenue45464340
Total operating expense218221207197
Selling / general / administrative173175164157
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income36373435
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax36383336
Income after tax30262224
Income tax, total6121112
Net income30262224
Total adjustments to net income--------
Net income before extra. items30262224
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items30262224
Inc. avail. to common incl. extra. items30262224
Diluted net income30262224
Dilution adjustment--------
Diluted weighted average shares25252526
Diluted EPS excluding extraordinary itemsvalue per share1.201.030.890.92
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share1.201.030.890.92